Paper Title
Novel drug delivery system for insulin
Article Identifiers
: Authors
Keywords
Abstract
A metabolic condition called diabetes mellitus is characterised by hyperglycemia, glycosuria, and hyperlipidemia. The current medication delivery techniques for the management of diabetic mellitus (DM) make it difficult to deliver medications to the target site in a reliable and secure manner. Therefore, research into new delivery methods for diabetes medications is Novel drug delivery system, followed by the commercialization of these medications. The goal of the current review is to compile the most recent research on Novel drug delivery systems (NDDSs) for diabetics, with a focus on particulate, vesicular, and other systems. It is studied from this review that, to overcome the issues with the conventional dosage forms and to gain the end users' trust in the higher acceptability, it is discovered that the curiosity to develop NDDSs of anti-diabetic drugs with special attention to the nanoparticulate system followed by microparticulate and lipid-based system is gradually emerging. It was summerised that the unique potential of providing physical stability, sustained, and sitespecific drug delivery for a scheduled period of time can open new vistas for precise, safe, and effective treatment of diabetes mellitus in the current scientific landscape where the field of novel drug delivery system has been recognised for its tangible benefits. Key Words: “nanoparticle”, “microparticle”, “liposomes”, “niosomes”, “transdermal systems”, “insulin”, “antidiabetic drugs” and “novel drug delivery systems”
Downloads
How To Cite (APA)
Santosh Negi , Santosh Negi , Parul Bisht, & Dr.Shivanand Patil (June-2023). Novel drug delivery system for insulin . INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT, 8(6), e232-e241. https://ijnrd.org/papers/IJNRD2306432.pdf
Issue
Volume 8 Issue 6, June-2023
Pages : e232-e241
Other Publication Details
Paper Reg. ID: IJNRD_199989
Published Paper Id: IJNRD2306432
Downloads: 000122255
Research Area: Pharmacy
Author Type: Indian Author
Country: Nanital , Uttrakhand , India
Published Paper PDF: https://ijnrd.org/papers/IJNRD2306432.pdf
Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRD2306432
About Publisher
Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)
UGC CARE JOURNAL PUBLICATION | ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publisher: IJNRD (IJ Publication) Janvi Wave | IJNRD.ORG | IJNRD.COM | IJPUB.ORG
Copyright & License
© 2025 — Authors hold the copyright of this article. This work is licensed under a Creative Commons Attribution 4.0 International License. and The Open Definition.
You are free to share, adapt, and redistribute the material, provided proper credit is given to the original author. 🛡️ Disclaimer: The content, data, and findings in this article are based on the authors’ research and have been peer-reviewed for academic purposes only. Readers are advised to verify all information before practical or commercial use. The journal and its editorial board are not liable for any errors, losses, or consequences arising from its use.
Publication Timeline
Article Preview: View Full Paper
Call For Paper
IJNRD is a Scholarly Open Access, Peer-Reviewed, Refereed, and UGC CARE Journal Publication with a High Impact Factor of 8.76 (calculated by Google Scholar & Semantic Scholar | AI-Powered Research Tool). It is a Multidisciplinary, Monthly, Low-Cost, and Transparent Peer Review Journal Publication that adheres to the UGC CARE 2025 Peer-Reviewed Journal Policy and aligns with Scopus Journal Publication standards to ensure the highest level of research quality and credibility.
IJNRD offers comprehensive Journal Publication Services including indexing in all major databases and metadata repositories, Digital Object Identifier (Crossref DOI) assignment for each published article with additional fees, citation generation tools, and full Open Access visibility to enhance global research reach and citation impact.
The INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to advance applied, theoretical, and experimental research across diverse academic and professional fields. The journal promotes global knowledge exchange among researchers, developers, academicians, engineers, and practitioners, serving as a trusted platform for innovative, peer-reviewed journal publication and scientific collaboration.
Indexing Coverage: Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar (AI-Powered Research Tool), Microsoft Academic, Academia.edu, arXiv.org, ResearchGate, CiteSeerX, ResearcherID (Thomson Reuters), Mendeley, DocStoc, ISSUU, Scribd, and many other recognized academic repositories.
How to submit the paper?
By Our website
Click Here to Submit Paper Online
You can now publish your research in IJNRD. IJNRD is a Transparent Peer-Reviewed Open Access Journal Publication (Refereed Journal), aligning with New UGC and UGC CARE recommendations.
For more details, refer to the official notice: UGC Public Notice
Submit Paper Online
Important Dates for Current issue
Paper Submission Open For: December 2025
Current Issue: Volume 10 | Issue 12 | December 2025
Impact Factor: 8.76
Last Date for Paper Submission: Till 31-Dec-2025
Notification of Review Result: Within 1-2 Days after Submitting paper.
Publication of Paper: Within 01-02 Days after Submititng documents.
Frequency: Monthly (12 issue Annually).
Journal Type: IJNRD is an International Peer-reviewed, Refereed, and Open Access Journal with Transparent Peer Review as per the new UGC CARE 2025 guidelines, offering low-cost multidisciplinary publication with Crossref DOI and global indexing.
Subject Category: Research Area
Call for Paper: More Details
Approval, Licenses and Indexing: More Details
